AIM2 and ovarian cancer: To evaluate the clinical significance of the identified inflammasome-related genes in ovarian cancer transformation, we collected a cohort of clinical samples (ES, n = 13; CCC, n = 15; EC, n = 15) and immunostained them with anti-AIM2 antibody.